Medical Journals

Regulatory Interactions Between Ubiquinol Oxidation and Ubiquinone Reduction Sites in the Dimeric Cytochrome Bc1 Complex.

Authors:
  • Covian Raul
  • Trumpower Bernard L

From: Department of Biochemistry, Dartmouth Medical School, Hanover, New Hampshire 03755, USA.

The Journal of biological chemistry

  • Publish Date: Oct 2006
  • ISSN: 0021-9258
  • Volume: 281
  • Issue: 41
  • Pages: 30925-32
  • Medium: Print
  • Language: English
  • Citation (JAMA): Covian Raul, Trumpower Bernard L, et al. Regulatory Interactions Between Ubiquinol Oxidation and Ubiquinone Reduction Sites in the Dimeric Cytochrome Bc1 Complex.. J. Biol. Chem. Oct 2006;281:30925-32

Abstract

We have obtained evidence for conformational communication between ubiquinol oxidation (center P) and ubiquinone reduction (center N) sites of the yeast bc1 complex dimer by analyzing antimycin binding and heme bH reduction at center N in the presence of different center P inhibitors. When stigmatellin was occupying center P, concentration-dependent binding of antimycin occurred only to half of the center N sites. The remaining half of the bc1 complex bound antimycin with a slower rate that was independent of inhibitor concentration, indicating that a slow conformational change needed to occur before half of the enzyme could bind antimycin. In contrast, under conditions where the Rieske protein was not fixed proximal to heme bL at center P, all center N sites bound antimycin with fast and concentration-dependent kinetics. Additionally, the extent of fast cytochrome b reduction by menaquinol through center N in the presence of stigmatellin was approximately half of that observed when myxothiazol was bound at center P. The reduction kinetics of the bH heme by decylubiquinol in the presence of stigmatellin or myxothiazol were also consistent with a model in which fixation of the Rieske protein close to heme bL in both monomers allows rapid binding of ligands only to one center N. Decylubiquinol at high concentrations was able to abolish the biphasic binding of antimycin in the presence of stigmatellin but did not slow down antimycin binding rates. These results are discussed in terms of half-of-the-sites activity of the dimeric bc1 complex.

Mesh Headings (Keywords): Antimycin A, Binding Sites, Cytochromes b, Dimerization, Dose-Response Relationship, Drug, Electron Transport Complex III, Heme, Iron-Sulfur Proteins, Kinetics, Models, Biological, Protein Binding, Protein Conformation, Saccharomyces cerevisiae, Time Factors, Ubiquinone


Check for Full Text / PubMed Unique Identifier (PMID): 16908520


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.